Re: Conditional Survival of Patients with Metastatic Testicular Germ Cell Tumors Treated with First-Line Curative Therapy

被引：0
|
作者：
Richie, Jerome P.
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 01期
关键词：
D O I：
10.1016/j.juro.2016.09.095
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [21] Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
    Fankhauser, Christian Daniel
    Sander, Sophia
    Roth, Lisa
    Gross, Oliver
    Eberli, Daniel
    Sulser, Tullio
    Seifert, Burkhardt
    Beyer, Joerg
    Hermanns, Thomas
    BRITISH JOURNAL OF CANCER, 2018, 118 (06) : 825 - 830
  • [22] Changeable prognosis and associated prognostic factors for conditional survival estimates in metastatic renal cell carcinoma patients receiving the first-line targeted therapy.
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Park, Se Hoon
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    Seo, Seong Il
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy
    Murray, Matthew J.
    Bailey, Shivani
    Heinemann, Katja
    Mann, Jillian
    Goebel, Ulrich K.
    Saran, Frank
    Hale, Juliet P.
    Calaminus, Gabriele
    Nicholson, James C.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (03) : 621 - 635
  • [24] Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy
    Demircan, Nazim Can
    Dane, Faysal
    Ozturk, Mehmet Akif
    Babacan, Nalan Akgul
    Besiroglu, Mehmet
    Kaya, Serap
    Ercelep, Ozlem
    Tanrikulu, Eda
    Halil, Suleyman
    Koca, Sinan
    Alan, Ozkan
    Hasano, Rahip
    Yumuk, Perran Fulden
    JOURNAL OF BUON, 2019, 24 (04): : 1494 - 1500
  • [25] High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy
    Hapakova, Nikola
    Sestakova, Zuzana
    Holickova, Andrea
    Hurbanova, Lenka
    Miskovska, Vera
    Chovanec, Michal
    Rejlekova, Katarina
    Svetlovska, Daniela
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Chovanec, Miroslav
    Mego, Michal
    CLINICAL GENITOURINARY CANCER, 2019, 17 (05) : E1020 - E1025
  • [26] Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Patil, S.
    Figlin, R. A.
    Hutson, T. E.
    Michaelson, M. D.
    Negrier, S.
    Kim, S. T.
    Huang, X.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Surveillance of patients with complete response following first-line chemotherapy for germ cell tumors (GCTs)
    Arunothai, S.
    Sripaiboonkij, N.
    Chansriwong, P.
    ANNALS OF ONCOLOGY, 2024, 35 : S1524 - S1524
  • [28] Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer
    Butcher, Georgiana
    Howard, Harriet
    Sathianathen, Niranjan
    Catto, James W. F.
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2019, 76 (06) : 872 - 873
  • [29] Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer
    Huebner, Nicolai A.
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2020, 77 (01) : 132 - 133
  • [30] Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 32 - 33
12345